Results 161 to 170 of about 20,100 (304)
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 9, Issue S1, June 2025.
wiley +1 more source
Clinical Pharmacology: Advances and Applications, 2011 Maro Ohanian, Christian Cable, Kathleen Halka Department of Hematology/Oncology, Scott & White Healthcare and The Texas A&M Health Science Center, College of Medicine, Temple, TX, USA Objective: To describe how maintenance eculizumab ...
Halka K, Cable C, Ohanian M
doaj
European Journal of Clinical PharmacologyAbstract Purpose To describe, compare similarity of pharmacokinetic (PK), pharmacodynamic (PD) and efficacy of SB12 and reference eculizumab (ECU) and find clinically significant covariate relationships. Methods The PK, PD (terminal complement activity) and efficacy (LDH ...
Lee, Hyuna +4 more
openaire +2 more sources
In Reply to ‘Beneficial Effect of Eculizumab on Thrombotic Microangiopathies: Another Point of View’ [PDF]
, 2013 Jan Schmidtko, Sven Peine
openalex +1 more source
Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience [PDF]
, 2014 Alejandro Schcolnik‐Cabrera +6 more
openalex +1 more source
Targeted Therapy with Eculizumab for Inherited CD59 Deficiency [PDF]
, 2014 Britta Höchsmann +4 more
openalex +1 more source
Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature [PDF]
, 2015 Anuja Java +8 more
openalex +1 more source